D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This study seeks to examine the effects of D-cycloserine augmentation on cognitive
remediation for patients diagnosed with schizophrenia. We will test the hypotheses that
D-cycloserine will significantly improve cognitive performance, negative symptoms, and
measures of functioning compared to placebo when combined with eight weeks of cognitive
remediation. We expect that these effects will persist when assessed at six-month follow up.